StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3085% above fair value
$58.31−0.97 (-1.64%)

Close on Nov 18, 2026Market cap $2.00BP/E 39.7Yield –

Ingevity net income

Net income is the profit left for shareholders after every expense, interest and tax.

Ingevity's net income for the twelve months ending Jun 30, 2026 was $54.00M. For fiscal 2025 it was -$167.10M. The highest annual figure on record is $211.60M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$167.10M–
FY2024Dec 31, 2024-$430.30M–
FY2023Dec 31, 2023-$5.40M-102.6%
FY2022Dec 31, 2022$211.60M+79.2%
FY2021Dec 31, 2021$118.10M-34.9%
FY2020Dec 31, 2020$181.40M-1.3%
FY2019Dec 31, 2019$183.70M+8.6%
FY2018Dec 31, 2018$169.10M+33.7%
FY2017Dec 31, 2017$126.50M+259.4%
FY2016Dec 31, 2016$35.20M-55.8%
FY2015Dec 31, 2015$79.70M-38.2%
FY2014Dec 31, 2014$129.00M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$35.30M–
Q1 FY2026Mar 31, 2026$59.80M+191.7%
Q4 FY2025Dec 31, 2025-$84.60M-609.6%
Q3 FY2025Sep 30, 2025$43.50M–
Q2 FY2025Jun 30, 2025-$146.50M–
Q1 FY2025Mar 31, 2025$20.50M–
Q4 FY2024Dec 31, 2024$16.60M–
Q3 FY2024Sep 30, 2024-$107.20M-525.4%
Q2 FY2024Jun 30, 2024-$283.70M-899.2%
Q1 FY2024Mar 31, 2024-$56.00M-210.5%
Q4 FY2023Dec 31, 2023-$116.80M-848.7%
Q3 FY2023Sep 30, 2023$25.20M-66.6%
Q2 FY2023Jun 30, 2023$35.50M-40.6%
Q1 FY2023Mar 31, 2023$50.70M-16.6%
Q4 FY2022Dec 31, 2022$15.60M-46.8%
Q3 FY2022Sep 30, 2022$75.40M–
Q2 FY2022Jun 30, 2022$59.80M+35.0%
Q1 FY2022Mar 31, 2022$60.80M+24.8%
Q4 FY2021Dec 31, 2021$29.30M-36.3%
Q3 FY2021Sep 30, 2021-$4.20M-106.0%
Q2 FY2021Jun 30, 2021$44.30M+119.3%
Q1 FY2021Mar 31, 2021$48.70M+7.5%
Q4 FY2020Dec 31, 2020$46.00M+3.8%
Q3 FY2020Sep 30, 2020$69.90M+16.7%
Q2 FY2020Jun 30, 2020$20.20M-64.4%
Q1 FY2020Mar 31, 2020$45.30M+99.6%
Q4 FY2019Dec 31, 2019$44.30M+5.2%
Q3 FY2019Sep 30, 2019$59.90M+21.0%
Q2 FY2019Jun 30, 2019$56.80M+21.6%
Q1 FY2019Mar 31, 2019$22.70M-26.3%
Q4 FY2018Dec 31, 2018$42.10M+1.2%
Q3 FY2018Sep 30, 2018$49.50M+46.4%
Q2 FY2018Jun 30, 2018$46.70M+45.5%
Q1 FY2018Mar 31, 2018$30.80M+62.1%
Q4 FY2017Dec 31, 2017$41.60M+357.1%
Q3 FY2017Sep 30, 2017$33.80M–
Q2 FY2017Jun 30, 2017$32.10M–
Q1 FY2017Mar 31, 2017$19.00M–
Q4 FY2016Dec 31, 2016$9.10M–
Q3 FY2016Sep 30, 2016-$7.20M–

More Ingevity figures

See a number that looks wrong?